Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1482361rdf:typepubmed:Citationlld:pubmed
pubmed-article:1482361lifeskim:mentionsumls-concept:C0596981lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C1414083lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C1839839lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C1623036lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C0439659lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C1317658lld:lifeskim
pubmed-article:1482361lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:1482361pubmed:issue3lld:pubmed
pubmed-article:1482361pubmed:dateCreated1993-2-8lld:pubmed
pubmed-article:1482361pubmed:abstractTextIntracellular protein turnover of MDX, DMD and normal muscle was determined by [35S]methionine pulse-chase experiments and subsequent high resolution 2-D gel electrophoresis. In MDX myotubes intracellular degradation of short-lived and long-lived proteins was markedly increased by a factor of 1,4-2,1. In wildtype the rate of degradation of short-lived proteins was approximately 2.6%/h, whereas in MDX these proteins were degraded by 5.7%/h. Long-lived proteins were degraded in wildtype at a rate of 1.8%/h, and in MDX at a rate of 2.5%/h. Furthermore, we have described a 51.000 Da protein with an IEP of 5.1 (p51/5.1), whose net content is highly and specifically reduced in cultured MDX and DMD muscle cells as well as in isolated MDX muscle fibers. Treatment with calcium-channel blockers Dantrolene and Verapamil inhibited the degradation of p51/5.1 in MDX myotubes by more than 90% in contrast to controls.lld:pubmed
pubmed-article:1482361pubmed:languageenglld:pubmed
pubmed-article:1482361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:citationSubsetIMlld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1482361pubmed:statusMEDLINElld:pubmed
pubmed-article:1482361pubmed:monthDeclld:pubmed
pubmed-article:1482361pubmed:issn0006-291Xlld:pubmed
pubmed-article:1482361pubmed:authorpubmed-author:RodemannH PHPlld:pubmed
pubmed-article:1482361pubmed:authorpubmed-author:KämperAAlld:pubmed
pubmed-article:1482361pubmed:issnTypePrintlld:pubmed
pubmed-article:1482361pubmed:day30lld:pubmed
pubmed-article:1482361pubmed:volume189lld:pubmed
pubmed-article:1482361pubmed:ownerNLMlld:pubmed
pubmed-article:1482361pubmed:authorsCompleteYlld:pubmed
pubmed-article:1482361pubmed:pagination1484-90lld:pubmed
pubmed-article:1482361pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:meshHeadingpubmed-meshheading:1482361-...lld:pubmed
pubmed-article:1482361pubmed:year1992lld:pubmed
pubmed-article:1482361pubmed:articleTitleAlterations of protein degradation and 2-D protein pattern in muscle cells of MDX and DMD origin.lld:pubmed
pubmed-article:1482361pubmed:affiliationDevelopmental Biology Unit, University of Bielefeld, Germany.lld:pubmed
pubmed-article:1482361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1482361pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1482361pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1482361lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1482361lld:pubmed